Guest Posted December 21, 2010 Share Posted December 21, 2010 IRCC is actively working with NovaRx to enroll patients in a research study of Lucanix, an investigational lung cancer vaccine. This vaccine is currently in Phase III trials. You can reach them at (877) 680-IRCC (4722) and they can answer most if not all of your questions about NSCLC and if your loved one will qualify. Hope this helps. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.